Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 13,552 | 11,860 | 45,392 | 24,586 | 29,487 |
| Operating Income | -13,552 | -11,860 | -45,392 | -24,586 | -29,487 |
| Other Income | 1,013 | 1,053 | 1,168 | 1,183 | 1,890 |
| Pre-tax Income | -12,539 | -10,807 | -44,224 | -23,403 | -27,597 |
| Net Income Continuous | -12,539 | -10,807 | -44,224 | -23,403 | -27,597 |
| Net Income | $-12,539 | $-10,807 | $-44,224 | $-23,403 | $-27,597 |
| EPS Basic Total Ops | -0.26 | -0.22 | -0.92 | -0.48 | -0.66 |
| EPS Basic Continuous Ops | -0.26 | -0.22 | -0.92 | -0.48 | -0.66 |
| EPS Diluted Total Ops | -0.26 | -0.22 | -0.92 | -0.48 | -0.58 |
| EPS Diluted Continuous Ops | -0.26 | -0.22 | -0.92 | -0.48 | -0.64 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.22 | -0.18 | -0.48 | -0.57 |
| EBITDA(a) | $-13,185 | $-11,729 | $-45,174 | $-24,366 | $-29,227 |